Zanti, M.* et al. A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2. Hum. Mutat. 2023:17 (2023)
Scala, M.* et al. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum. Mutat. 43, 403-419 (2022)
Smirnov, D. ; Schlieben, L.D. ; Peymani, F. ; Berutti, R. & Prokisch, H. Guidelines for clinical interpretation of variant pathogenicity using RNA phenotypes. Hum. Mutat. 43, 1056-1070 (2022)
Itai, T.* et al. De novo variants in CELF2  that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy. Hum. Mutat. 42, 66-76 (2021)
Neuser, S.* et al. Clinical, neuroimaging and molecular spectrum of TECPR2-associated hereditary sensory and autonomic neuropathy with intellectual disability. Hum. Mutat. 42, 762-776 (2021)
Stenton, S. et al. Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance. Hum. Mutat. 42, 310-319 (2021)
Torraco, A.* et al. Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation. Hum. Mutat. 42, 699-710 (2021)
Ascari, G.* et al. Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility. Hum. Mutat. 41, 998-1011 (2020)
Saoura, M.* et al. Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3 '-end processing. Hum. Mutat. 40, 1731-1748 (2019)
Suleiman, J.* et al. Homozygous loss-of-function variants of TASP1, a gene encoding an activator of the histone methyltransferases KMT2A and KMT2D, cause a syndrome of developmental delay, happy demeanor, distinctive facial features, and congenital anomalies. Hum. Mutat. 40, 1985-1992 (2019)
Bruni, F.* et al. Clinical, biochemical, and genetic features associated with VARS2-related mitochondrial disease. Hum. Mutat. 39, 563-578 (2018)
El-Hattab, A.W.* et al. Molecular and clinical spectra of FBXL4 deficiency. Hum. Mutat. 38, 1649-1659 (2017)
Kreimer, A.* et al. Predicting gene expression in massively parallel reporter assays: A comparative study. Hum. Mutat. 38, 1240-1250 (2017)
Wambach, J.A.* et al. Survival among children with “Lethal” congenital contracture syndrome 11 caused by novel mutations in the gliomedin gene (GLDN). Hum. Mutat. 38, 1477-1484 (2017)
Wortmann, S.B. et al. Biallelic variants in WARS2 encoding mitochondrial tryptophanyl-tRNA synthase in six individuals with mitochondrial encephalopathy. Hum. Mutat. 38, 1786-1795 (2017)
Bögershausen, N.* et al. Mutation update for Kabuki syndrome genes KMT2D and KDM6A and further delineation of X-linked Kabuki syndrome subtype 2. Hum. Mutat. 37, 847-864 (2016)
Diodato, D.* et al. VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Hum. Mutat. 35, 983-989 (2014)
Baruffini, E.* et al. MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum. Mutat. 34, 1501-1509 (2013)
Parzefall, T.* et al. Cytoplasmic mislocalization of POU3F4 due to novel mutations leads to deafness in humans and mice. Hum. Mutat. 34, 1102-1110 (2013)
Horn, D.* et al. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits. Hum. Mutat. 31, E1851-E1860 (2010)
Molatore, S. et al. A novel germline CDKN1B mutation causing multiple endocrine tumors: Clinical, genetic and functional characterization. Hum. Mutat. 31, E1825-E1835 (2010)
Fritsche, L.G.* et al. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum. Mutat. 30, 1048-1053 (2009)
Collin, R.W.* et al. Involvement of DFNB59 mutations in autosomal recessive nonsyndromic hearing impairment. Hum. Mutat. 28, 718-723 (2007)
Fisher, S.A.* et al. Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD). Hum. Mutat. 28, 406-413 (2007)
Schoenborn, V.* et al. Sample selection algorithm to improve quality of genotyping from plasma-derived DNA: To separate the wheat from the chaff. Hum. Mutat. 28, 1141-1149 (2007)
Kalay, E.* et al. Mutations in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene cause autosomal recessive nonsyndromic hearing loss. Hum. Mutat. 27, 633-639 (2006)
Jaremko, M.* et al. MALDI-TOF MS and TaqMan® assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum. Mutat. 25, 232-238 (2005)
Rubie, C.* et al. Sequence diversity of KIAA0027/MLC1: Are megalencephalic leukoencephalopathy and schizophrenia allelic disorders? Hum. Mutat. 21, 45-52 (2003)
Calzada-Wack, J. et al. Analysis of the PTCH Coding Region in Human Rhabdomyosarcoma. Hum. Mutat. 20, 233-234 (2002)
von Brederlow, B.* et al. Identification and In Vitro Expression of Novel CDH23 Mutations of Patients with Usher Syndrome Type 1D. Hum. Mutat. 19, 268-273 (2002)
Werner, M. et al. Large-Scale Determination of SNP Allele Frequencies in DNA Pools Using MALDI-TOF Mass Spectrometry. Hum. Mutat. 20, 57-64 (2002)